XLF: The Financial Sector At Crossroads

Seeking Alpha - Thu, 04/09/2026 - 15:20

Albemarle: Why Sodium-Ion Technology Makes This Lithium Giant A Value Trap

Seeking Alpha - Thu, 04/09/2026 - 15:19

Dynagas LNG Partners LP Non-GAAP EPS of $1.26

Seeking Alpha - Thu, 04/09/2026 - 15:19

CoreWeave announces upsize and pricing of $1.75B senior notes

Seeking Alpha - Thu, 04/09/2026 - 15:17

Texas Pacific Land plunges after CEO of top shareholder Horizon Kinetics dies

Seeking Alpha - Thu, 04/09/2026 - 15:17

Transcat acquires Costa Rica-based SCM for $13 million, enters Latin America

Seeking Alpha - Thu, 04/09/2026 - 15:12

IVT: Sunbelt Retail Is Getting Pricey, But Here's My 'Buy Price'

Seeking Alpha - Thu, 04/09/2026 - 15:09

Simulations Plus Non-GAAP EPS of $0.35 beats by $0.05, revenue of $24.3M beats by $2.64M

Seeking Alpha - Thu, 04/09/2026 - 15:09

Block: A 'Buy' As Banking Actives Expand And Efficiency Rises

Seeking Alpha - Thu, 04/09/2026 - 15:09

Sea: Strong Fundamentals, Weak Sentiment - A Buy On Reinvestment Phase

Seeking Alpha - Thu, 04/09/2026 - 15:07

UnitedHealth Group: Don't Drink The CMS Kool-Aid

Seeking Alpha - Thu, 04/09/2026 - 15:05

Starmer “fed up” with volatile energy prices due to Putin, Trump

Seeking Alpha - Thu, 04/09/2026 - 15:02

Tencent: Not A Bargain Despite YTD Share Price Weakness

Seeking Alpha - Thu, 04/09/2026 - 15:02

Brunello Cucinelli S.p.A. (BCUCY) Q1 2026 Sales/ Trading Statement Call - Slideshow

Seeking Alpha - Thu, 04/09/2026 - 15:01

Stolt-Nielsen Limited 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Thu, 04/09/2026 - 15:00

Freeport-McMoRan: Fade The Copper Rally

Seeking Alpha - Thu, 04/09/2026 - 15:00

Blue Owl Capital: The Market Thinks Disaster Is Coming, I Think It Is Wrong

Seeking Alpha - Thu, 04/09/2026 - 15:00

NovaGold initiated at Overweight by Morgan Stanley, underpinned by top-tier Donlin Gold project

Seeking Alpha - Thu, 04/09/2026 - 14:57

CubeSmart: A Historically High Yield, But Still A Hold

Seeking Alpha - Thu, 04/09/2026 - 14:55

Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide

Seeking Alpha - Thu, 04/09/2026 - 14:49

Pages